BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han J, He Y, Zhao H, Xu X. Hypoxia inducible factor-1 promotes liver fibrosis in nonalcoholic fatty liver disease by activating PTEN/p65 signaling pathway. J Cell Biochem. 2019;120:14735-14744. [PMID: 31009107 DOI: 10.1002/jcb.28734] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Asare-Bediako B, Noothi SK, Li Calzi S, Athmanathan B, Vieira CP, Adu-Agyeiwaah Y, Dupont M, Jones BA, Wang XX, Chakraborty D, Levi M, Nagareddy PR, Grant MB. Characterizing the Retinal Phenotype in the High-Fat Diet and Western Diet Mouse Models of Prediabetes. Cells 2020;9:E464. [PMID: 32085589 DOI: 10.3390/cells9020464] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
2 Foglia B, Novo E, Protopapa F, Maggiora M, Bocca C, Cannito S, Parola M. Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis. Cells 2021;10:1764. [PMID: 34359934 DOI: 10.3390/cells10071764] [Reference Citation Analysis]
3 Hathaway-Schrader JD, Poulides NA, Carson MD, Kirkpatrick JE, Warner AJ, Swanson BA, Taylor EV, Chew ME, Reddy SV, Liu B, Westwater C, Novince CM. Specific Commensal Bacterium Critically Regulates Gut Microbiota Osteoimmunomodulatory Actions During Normal Postpubertal Skeletal Growth and Maturation. JBMR Plus 2020;4:e10338. [PMID: 32161843 DOI: 10.1002/jbm4.10338] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
4 Plotogea OM, Ilie M, Bungau S, Chiotoroiu AL, Stanescu AMA, Diaconu CC. Comprehensive Overview of Sleep Disorders in Patients with Chronic Liver Disease. Brain Sci 2021;11:142. [PMID: 33499194 DOI: 10.3390/brainsci11020142] [Reference Citation Analysis]
5 Lopez-Lopez V, Martínez-Caceres C, Ferreras D, Peña-Moral J, Cruz J, Royo-Villanova M, Rodríguez JM, Fernández-Hernández JA, Zambudio AR, Pons JA, Martínez-Barba E, Sánchez-Bueno F, Campos RR, Ramírez P. Biomarkers of Early Liver Graft Damage in Circulatory Death and Brain Death Donors: A Propensity Score Matching Analysis. Transplant Proc 2021:S0041-1345(21)00625-4. [PMID: 34602295 DOI: 10.1016/j.transproceed.2021.07.055] [Reference Citation Analysis]
6 Ye M, Wang S, Sun P, Qie J. Integrated MicroRNA Expression Profile Reveals Dysregulated miR-20a-5p and miR-200a-3p in Liver Fibrosis. Biomed Res Int 2021;2021:9583932. [PMID: 34235224 DOI: 10.1155/2021/9583932] [Reference Citation Analysis]
7 Cai H, Bai Z, Ge RL. Hypoxia-inducible factor-2 promotes liver fibrosis in non-alcoholic steatohepatitis liver disease via the NF-κB signalling pathway. Biochem Biophys Res Commun 2021;540:67-74. [PMID: 33450482 DOI: 10.1016/j.bbrc.2021.01.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hirota K. HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review. Biomedicines 2021;9:468. [PMID: 33923349 DOI: 10.3390/biomedicines9050468] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yu JW, Li S, Bao LD, Wang L. Piperine treating sciatica through regulating inflammation and MiR-520a/P65 pathway. Chin J Nat Med 2021;19:412-21. [PMID: 34092292 DOI: 10.1016/S1875-5364(21)60040-7] [Reference Citation Analysis]
10 Li X, Zhang Q, Wang Z, Zhuang Q, Zhao M. Immune and Metabolic Alterations in Liver Fibrosis: A Disruption of Oxygen Homeostasis? Front Mol Biosci 2022;8:802251. [DOI: 10.3389/fmolb.2021.802251] [Reference Citation Analysis]
11 Li J, Qi J, Tang Y, Liu H, Zhou K, Dai Z, Yuan L, Sun C. A nanodrug system overexpressed circRNA_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p/miR-320a and ABCA1/CPT1 axis. J Nanobiotechnology 2021;19:363. [PMID: 34789275 DOI: 10.1186/s12951-021-01108-8] [Reference Citation Analysis]
12 Isaza SC, Del Pozo-Maroto E, Domínguez-Alcón L, Elbouayadi L, González-Rodríguez Á, García-Monzón C. Hypoxia and Non-alcoholic Fatty Liver Disease. Front Med (Lausanne) 2020;7:578001. [PMID: 33195326 DOI: 10.3389/fmed.2020.578001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Shi J, Xiao P, Liu X, Chen Y, Xu Y, Fan J, Yin Y. Notch3 Modulates Cardiac Fibroblast Proliferation, Apoptosis, and Fibroblast to Myofibroblast Transition via Negative Regulation of the RhoA/ROCK/Hif1α Axis. Front Physiol 2020;11:669. [PMID: 32695015 DOI: 10.3389/fphys.2020.00669] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Li X, Shao S, Li H, Bi Z, Zhang S, Wei Y, Bai J, Zhang R, Ma X, Ma B, Zhang L, Xie C, Ning W, Zhou H, Yang C. Byakangelicin protects against carbon tetrachloride-induced liver injury and fibrosis in mice. J Cell Mol Med 2020;24:8623-35. [PMID: 32643868 DOI: 10.1111/jcmm.15493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Wang Y, Duo D, Yan Y, He R, Wu X. Magnesium lithospermate B ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and its potential targets. Biomed Pharmacother 2020;130:110560. [PMID: 34321157 DOI: 10.1016/j.biopha.2020.110560] [Reference Citation Analysis]
16 Chen X, Wang Z, Han S, Wang Z, Zhang Y, Li X, Xia N, Yu W, Jia C, Ni Y, Pu L. Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk/Hif1α and remodeling liver inflammatory environment. Cell Death Dis 2021;12:1123. [PMID: 34853322 DOI: 10.1038/s41419-021-04403-2] [Reference Citation Analysis]
17 Yuan S, Wei C, Liu G, Zhang L, Li J, Li L, Cai S, Fang L. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1α/SLC7A11 pathway. Cell Prolif 2021;:e13158. [PMID: 34811833 DOI: 10.1111/cpr.13158] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Qin C, Luo L, Cui Y, Jiang L, Li B, Lou Y, Weng Z, Lou J, Liu C, Weng C, Wang Z, Ji Y. Anti-Autophagy Mechanism of Zhi Gan Prescription Based on Network Pharmacology in Nonalcoholic Steatohepatitis Rats. Front Pharmacol 2021;12:708479. [PMID: 34349657 DOI: 10.3389/fphar.2021.708479] [Reference Citation Analysis]
19 Zisser A, Ipsen DH, Tveden-Nyborg P. Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis-Roles as Putative Treatment Targets? Biomedicines 2021;9:365. [PMID: 33807461 DOI: 10.3390/biomedicines9040365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Holzner LMW, Murray AJ. Hypoxia-Inducible Factors as Key Players in the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. Front Med (Lausanne) 2021;8:753268. [PMID: 34692739 DOI: 10.3389/fmed.2021.753268] [Reference Citation Analysis]
21 Kotlyarov S, Bulgakov A. Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease. Cells 2021;10:2978. [PMID: 34831201 DOI: 10.3390/cells10112978] [Reference Citation Analysis]
22 Luo X, Luo SZ, Xu ZX, Zhou C, Li ZH, Zhou XY, Xu MY. Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease. World J Gastroenterol 2021; 27(14): 1419-1434 [PMID: 33911465 DOI: 10.3748/wjg.v27.i14.1419] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Mahmoudi A, Butler AE, Jamialahmadi T, Sahebkar A. The role of exosomal miRNA in nonalcoholic fatty liver disease. J Cell Physiol 2022. [PMID: 35137416 DOI: 10.1002/jcp.30699] [Reference Citation Analysis]
24 Ali MA, Mahmoud SA, Alkhedaide A, Soliman MM, Al-shafie TA, El-sayed YS, Shukry M, Ghamry HI, Elblehi SS. Boosting effects of Cranberry and Cinnamaldehyde for pioglitazone amelioration of liver steatosis in rat via suppression of HIF-1α/Smad/β-catenin signaling. Journal of Functional Foods 2022;90:104973. [DOI: 10.1016/j.jff.2022.104973] [Reference Citation Analysis]